Complicated Case of Multidrug-Resistant Tuberculosis with Multiple Comorbidities, Successfully Treated After Several Treatment Modifications [0.03%]
经过多次治疗调整后成功治愈的合并多种疾病的多位耐药肺结核的复杂病例
Benedreky Leo,Heni Retnowulan
Benedreky Leo
A 59-year-old man with relapsed pulmonary TB developed rifampin resistance. He presented with chronic untreated hepatitis B, which developed into liver cirrhosis, type 2 diabetes with diabetic retinopathy, and osteoarthritis of right knee. ...
Severe and Apparently Irreversible Pulmonary Arterial Hypertension in a Patient with Ostium Secundum Atrial Septal Defect - A Successful Case of Treat and Close Strategy [0.03%]
房间隔缺损二孔型患者出现严重且似乎不可逆的肺动脉高压：治疗并封闭策略的成功案例
Alexandra Briosa,Filipa Ferreira,João Santos et al.
Alexandra Briosa et al.
Irreversible pulmonary arterial hypertension is considered a contraindication for surgical or percutaneous closure of atrial septal defects (ASD) due to risk of right heart failure. We present a case of 37 years-old woman who was referred t...
Erratum: Erratum [0.03%]
勘误：错误更正
Rosie S Jones,Patricia S Smith,Paul H Berg et al.
Rosie S Jones et al.
[This corrects the article DOI: 10.1177/11795484221119316.]. © The Author(s) 2022.
Combined Use of ECMO, Prone Positioning, and APRV in the Management of Severe COVID-19 Patients [0.03%]
ECMO、俯卧位和APRV在严重COVID-19患者中的联合应用管理
Stephanie L Ong,Hossam Tantawy,Roland Assi et al.
Stephanie L Ong et al.
Background: Severe COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) may warrant extracorporeal membrane oxygenation (ECMO). We evaluated the safety and physiologic changes in oxygenation and hemodynamic prof...
Sarah Jayne Sutton,Graey Wolfley,Sierra Canapp et al.
Sarah Jayne Sutton et al.
Spontaneous pneumomediastinum (SPM) is defined as free air in the mediastinum thought to be due to non-traumatic rupture of marginal alveoli without evidence of underlying lung disease. Secondary causes must be excluded, including perforati...
Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19 [0.03%]
LY3127804（抗血管生成素-2抗体）治疗住院肺炎和疑似或确认新冠肺炎患者的疗效和安全性：随机双盲安慰剂对照临床试验
Rosie S Jones,Patricia S Smith,Paul H Berg et al.
Rosie S Jones et al.
Background: Severe cases of coronavirus disease 2019 (COVID-19) are characterized by progressive respiratory failure and the development of acute respiratory distress syndrome (ARDS), with high mortality rates for patient...
Efficacy of Veno-Arterial Extracorporeal Life Support in Adult Patients with Refractory Cardiogenic Shock [0.03%]
难治性心源性休克成人患者体外生命支持的有效性
E R Kurniawati,Smj van Kuijk,Npa Vranken et al.
E R Kurniawati et al.
Background: This study aimed to describe the efficacy of veno-arterial extracorporeal life support (VA-ECLS) through early lactate clearance and pH restoration and assess the potential association with 30-day survival fol...
Immune Response to SARS-CoV-2 Vaccine among Heart Transplant Recipients: A Systematic Review [0.03%]
心脏移植受者对SARS-CoV-2疫苗的免疫反应：系统性回顾
Saeed Shoar,Adriana C Carolina Prada-Ruiz,Gabriel Patarroyo-Aponte et al.
Saeed Shoar et al.
Background: Heart transplant (HTX) recipients are at a significantly higher risk of adverse clinical outcomes, due to chronic immunosuppression and co-existence of other chronic conditions, when contracting the SARS-CoV-2...
Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan [0.03%]
日本新型冠状病毒肺炎患者的SARS-CoV-2核衣壳和刺突蛋白抗体的检测
Hiroshi Furukawa,Shomi Oka,Takashi Higuchi et al.
Hiroshi Furukawa et al.
Objectives: Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Serological testing for anti-SARS-CoV-2 nucleocapsid (N) antibodies (Abs) and anti-SARS-CoV-2 ...
Prevalence, Presentation and Outcomes of Silent Hypoxemia in COVID-19 [0.03%]
新冠肺炎中“隐形低氧血症”的流行率、表现及预后情况分析
Amélia Ribeiro,Mauro Mendonça,Cláudia Sabina Sousa et al.
Amélia Ribeiro et al.
Dyspnea is reported in a minority of patients affected by coronavirus disease 2019 (COVID-19). Even patients with pneumonia can present hypoxemia without any respiratory distress, a phenomenon known as "silent" or "happy hypoxemia". During ...